Product, Process and Packaging Optimization for Development of Stable Oral Capsule Formulation of Second-line Anti- Tubercular drug
Saved in:
Main Authors: | Amit Mukharya (Author), Shivang Chaudhary (Author), Nitin Laddha (Author), Arun Kumar Misra (Author) |
---|---|
Format: | Book |
Published: |
Archives of Global Professionals,
2011-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nephrotoxicity and ototoxic symptoms of injectable second-line anti-tubercular drugs among patients treated for MDR-TB in Ethiopia: a retrospective cohort study
by: Workineh Shibeshi, et al.
Published: (2019) -
Adverse drug reaction prevalence and mechanisms of action of first-line anti-tubercular drugs
by: Faisal Imam, et al.
Published: (2020) -
Tubercular uterocutaneous fistula after caesarean section: A case report
by: Aditi Jindal, et al.
Published: (2018) -
Paradoxical worsening of presumed tubercular serpiginous like choroiditis on anti-tubercular therapy
by: Priyanka1, et al.
Published: (2019) -
Tubercular pseudoaneurysm of the axillary artery
by: Lamk Kadiyani, et al.
Published: (2023)